1. 1. Narwariya A, Dhakar M, Jatav J, et al. (2022) Comparative study of hypo-fractionated radiotherapy versus conventional radiotherapy in breast cancer. Cureus, 14(9): e29147. DOI:10.7759/cureus.29147 [
DOI:10.7759/cureus.29147] 
2. Paraskevi T (2012) Quality of life outcomes in patients with breast cancer. Oncol Rev, 6(1): e2. DOI:10.4081/oncol.2012.e2 [
DOI:10.4081/oncol.2012.e2] 
3. Ghaderi I, Kaviani A, Fakhrejahani E, et al. (2014) Religious, cultural, and social beliefs of iranian rural women about breast cancer: A qualitative study. Arch Breast Cancer, 1(1): 25-31. DOI:10.19187/abc.20141125-31
4. Bride MBM, Neal L, Dilaveri CA, et al. (2013) Factors associated with surgical decision making in women with early-stage breast cancer: a literature review. J Women's Health, 22(3): 236-42. DOI:10.1089/jwh.2012.3969 [
DOI:10.1089/jwh.2012.3969] 
5. Amin SM and Faraj K (2023) Estimation of oesophageal surface dose in breast cancer patients undergoing supraclavicular irradiation by thermoluminescent dosimeter (TLD) and treatment planning system (TPS). Int J Radiat Res, 21(4): 647-52. DOI:10.61186/ijrr.21.4.647 [
DOI:10.61186/ijrr.21.4.647] 
6. Behmadi M, Gholamhosseinian H, Mohammadi M, et al. (2019) Evaluation of breast cancer radiation therapy techniques in outfield organs of rando phantom with thermoluminescence dosimeter. J Biomed Phys Eng, 9(2): 179-88. DOI: 10.31661/jbpe.v0i0.1067 [
DOI:10.31661/jbpe.v0i0.1067] 
7. Senkus-Konefka E, Jassem J (2006) Complications of breast-cancer radiotherapy. Clin Oncol, 18(3): 229-35. DOI:10.1016/j.clon.2005.11.004 [
DOI:10.1016/j.clon.2005.11.004] 
8. Reboucas LM, Campos CS, D'Amico GM, et al. (2019) Once‐weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial. Breast J, 25(5): 953-7. DOI:10.1111/tbj.13372 [
DOI:10.1111/tbj.13372] 
9. Rastogi K, Jain S, Bhatnagar AR, et al. (2018) A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients. Asia-Pac J Oncol Nurs, 5(1): 107-13. DOI:10.4103/apjon.apjon_46_17 [
DOI:10.4103/apjon.apjon_46_17] 
10. Wang S-L, Fang H, Song Y-W, et al. (2019) Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol, 20(3): 352-60. DOI:10.1016/S1470-2045(18)30813-1 [
DOI:10.1016/S1470-2045(18)30813-1] 
11. Kumbhaj P, Sharma R, Saini P, et al. (2013) A study of two different dose fractionation schedules of post mastectomy chest wall irradiation in carcinoma breast patients. Int J Med Sci Public Health, 2(4): 1001-5. DOI:10.5455/ijmsph.2013.040820131 [
DOI:10.5455/ijmsph.2013.040820131] 
12. Versmessen H, Vinh-Hung V, Van Parijs H, et al. (2012) Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy. BMC cancer, 12: 1-16. DOI:10.1186/1471-2407-12-495 [
DOI:10.1186/1471-2407-12-495] 
13. Parekh A, Dholakia AD, Zabranksy DJ, et al. (2018) Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume. Adv Radiat Oncol, 3(1): 8-15. DOI:10.1016/j.adro.2017.10.007 [
DOI:10.1016/j.adro.2017.10.007] 
14. Arsenault J, Parpia S, Goldberg M, et al. (2020) Acute toxicity and quality of life of hypofractionated radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys, 107(5): 943-8. DOI:10.1016/j.ijrobp.2020.03.049 [
DOI:10.1016/j.ijrobp.2020.03.049] 
15. Saber K, Madadizadeh F, Abdollahi-Dehkordi S, et al. (2024) Psychometric properties of the COVID-19 safety measures questionnaire in the employees of the radiation therapy center. J Educ Health Promot, 13(1): 95-101. DOI:10.4103/jehp.jehp_1007_22 [
DOI:10.4103/jehp.jehp_1007_22] 
16. Venigalla S, Guttmann DM, Jain V, et al. (2018) Trends and patterns of utilization of hypofractionated postmastectomy radiotherapy: a National Cancer Database analysis. Clin Breast Cancer, 18(5): e899-e908. DOI:10.1016/j.clbc.2018.02.009 [
DOI:10.1016/j.clbc.2018.02.009] 
17. Jd C (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341-6. DOI:10.1016/0360-3016(95)00060-C [
DOI:10.1016/0360-3016(95)00060-C] 
18. Chu C-N, Hu K-C, Wu RS-C, et al. (2021) Radiation-irritated skin and hyperpigmentation may impact the quality of life of breast cancer patients after whole breast radiotherapy. BMC cancer, 21: 1-8. DOI:10.1186/s12885-021-08047-5 [
DOI:10.1186/s12885-021-08047-5] 
19. Soonthornrak J, Amornwichet N, Shotelersuk K, et al. (2022) Toxicity and cosmetic outcome in hypofractionated radiation therapy for ductal carcinoma in situ after breast-conserving surgery: a preliminary report. Int J Radiat Res, 20(2): 383-7. DOI:10.52547/ijrr.20.2.19 [
DOI:10.52547/ijrr.20.2.19] 
20. Linares I, Tovar MI, Zurita M, et al. (2016) Hypofractionated breast radiation: Shorter scheme, lower toxicity. Clin Breast Cancer, 16(4): 262-8. DOI:10.1016/j.clbc.2015.09.012 [
DOI:10.1016/j.clbc.2015.09.012] 
21. Zhao S, Liu Y, Huang F, et al. (2017) The long-term outcome of adjuvant hypofractionated radiotherapy and conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer: a prospective analysis of 107 cases. J Thorac Dis, 9(10): 3840-50. DOI:10.21037/jtd.2017.09.125 [
DOI:10.21037/jtd.2017.09.125] 
22. Liu L, Yang Y, Guo Q, et al. (2020) Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiat Oncol, 15: 1-15. DOI: 10.1186/s13014-020-1463-1 [
DOI:10.1186/s13014-020-1463-1] 
23. Hashemi FA, Barzegartahamtan M, Mohammadpour RA, et al. (2016) Comparison of conventional and hypofractionated radiotherapy in breast cancer patients in terms of 5-year survival, locoregional recurrence, late skin complications and cosmetic results. Asian Pacific journal of cancer prevention: APJCP, 17(11): 4819-23. DOI:10.22034/APJCP.2016.17.11.4819
24. Gu L, Dai W, Fu R, et al. (2021) Comparing hypofractionated with conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer: a meta-analysis of randomized controlled trials. Front Oncol, 11: 753209. DOI:10.3389/fonc.2021.753209 [
DOI:10.3389/fonc.2021.753209] 
25. Schmeel LC, Koch D, Schmeel FC, et al. (2020) Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry. Radiother Oncol, 146: 172-9. DOI:10.1016/j.radonc.2020.02.018 [
DOI:10.1016/j.radonc.2020.02.018] 
26. Maiti S, Meyur S, Mandal BC, et al. (2021) Comparison of conventional and hypofractionated radiation after mastectomy in locally advanced breast cancer: a prospective randomised study on dosimetric evaluation and treatment outcome. J Radiother Pract, 20(1): 30-8. DOI:10.1017/S1460396919000992. [
DOI:10.1017/S1460396919000992]